Skip to main content

Table 2 Subject characteristics of the patients who quitted smoking.

From: Elevation of sputum matrix metalloproteinase-9 persists up to 6 months after smoking cessation: a research study

 

Asymptomatic smokers

Smokers with asthma

Chronic bronchitis/COPD

Subjects (n)

   

3 mo

6

4

7

6 mo

4

4

1

Female/Male

   

3 mo

3/3

3/1

4/3

6 mo

3/1

3/1

1/0

Age yrs

   

3 mo

47 ± 6

46 ± 2

59 ± 11

6 mo

50 ± 5

46 ± 2

57

Pack-yrs

   

3 mo

15 ± 10

21 ± 18

36 ± 14

6 mo

19 ± 11

21 ± 18

21

Post-bronchodilator

   

FVC L

   

3 mo

4.2 ± 0.65

3.7 ± 0.68

2.9 ± 0.48

6 mo

3.9 ± 0.67

3.7 ± 0.68

3.5

FVC % pred

   

3 mo

95 ± 6

99 ± 27

85 ± 9

6 mo

96 ± 6

99 ± 27

83

FEV1 L

   

3 mo

3.5 ± 0.68

3.0 ± 0.53

2.1 ± 0.43

6 mo

3.2 ± 0.71

3.0 ± 0.53

2.35

FEV1% pred

   

3 mo

96 ± 5

98 ± 26

75 ± 8

6 mo

97 ± 6

98 ± 26

70

FEV1/FVC

   

3 mo

83 ± 4

82 ± 2

71 ± 7

6 mo

82 ± 5

82 ± 2

82 ± 2